首页> 中文期刊> 《中华医学杂志(英文版)》 >Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors

Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors

         

摘要

Background:Classification of the pulmonary neuroendocrine tumor (pNET) categories is a step-wise process identified by the presence of necrosis and number of mitoses per 2 mm2.In neuroendocrine tumor pathology,Ki-67 was first described as a prognostic factor in the pancreas and incorporated into the grading system of digestive tract neuroendocrine neoplasms in the 2010 WHO classification.However,the significance of Ki-67 in pNETs was still a controversial issue.This study was to investigate the potentially diagnostic value of Ki-67 in pNETs.Methods:We retrieved 159 surgical specimens of pNETs,including 35 typical carcinoids (TCs),2 atypical carcinoid (ACs),28 largecell neuroendocrine carcinomas (LCNECs),94 small-cell lung cancers (SCLCs).Manual conventional method (MCM) and computer-assisted image analysis method (CLAM) were used to calculate the Ki-67 proliferative index.In CIAM,6 equivalent fields (500 × 500 μm) at 10× magnification were manually annotated for digital image analysis.Results:The Ki-67 index among the 4 groups with ranges of 0.38% to 12.66% for TC,4.34% to 29.48% for AC,30.67% to 93.74% for LCNEC,and 40.71% to 96.87% for SCLC.The cutoff value of Ki-67 index to distinguish low grade with high grade was 30.07%.For the univariate survival analyses in pNETs,both the overall survival and progression-free survival correlated with Ki-67 index.In addition,the Ki-67 index performed by CIAM was proved to be of great positive correlation with MCM.Conclusions:Ki-67 index counted by CIAM is a reliable method and can be a useful adjunct to dassify the low-and high-grade NETs.

著录项

  • 来源
    《中华医学杂志(英文版)》 |2019年第5期|551-561|共11页
  • 作者单位

    Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute,Beijing 100142, China;

    Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute,Beijing 100142, China;

    Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute,Beijing 100142, China;

    Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute,Beijing 100142, China;

    Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute,Beijing 100142, China;

    Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute,Beijing 100142, China;

    Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute,Beijing 100142, China;

    Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute,Beijing 100142, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号